Sensitization of Resistant Breast Cancer Cells with a Jumonji Family Histone Demethylase Inhibitor.

Singh, Balraj; Sarli, Vanessa N; Lucci, Anthony.

Afiliação

Singh B; Department of Breast Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Sarli VN; Morgan Welch Inflammatory Breast Cancer Research Program and Clinic, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Lucci A; Department of Breast Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.

Cancers (Basel) ; 14(11)2022 May 26.

Article em En | MEDLINE | ID: mdl-35681611

Palavras-chave

breast cancer epigenome; breast cancer relapse; cancer quiescence model; intra-tumoral heterogeneity; intrinsic resistance of cancer; metastasis prevention; quiescent cancer cells; resistant TNBC; targeting resistant cancer; tumor adaptability

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article